Graviti Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 49.00 Cr
as on 24-10-2024
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 363.25 Cr
as on 24-10-2024
- Satisfied Charges ₹ 160.00 Cr
as on 24-10-2024
- Revenue 29.02%
(FY 2023)
- Profit -110.34%
(FY 2023)
- Ebitda 2981.05%
(FY 2023)
- Net Worth -1.01%
(FY 2023)
- Total Assets 12.63%
(FY 2023)
About Graviti Pharmaceuticals
The Corporate was formerly known as Abhayam Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 49.00 Cr.
The company currently has active open charges totaling ₹363.25 Cr. The company has closed loans amounting to ₹160.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Graviti Pharmaceuticals Private Limited India is Murali Vasudeva as COMPANY SECRETARY. Dheeraj Gorukanti and Suguna Raman serve as directors at the Company.
- CIN/LLPIN
U24232TG2012PTC085058
- Company No.
085058
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Dec 2012
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Graviti Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dheeraj Gorukanti  | Managing Director | 27-Dec-2012 | Current |
| Murali Vasudeva | Company Secretary | 06-Oct-2019 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suguna Raman | Director | 27-Dec-2012 | Current |
Financial Performance of Graviti Pharmaceuticals.
Graviti Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.02% increase. The company also saw a substantial fall in profitability, with a 110.34% decrease in profit. The company's net worth dipped by a decrease of 1.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Graviti Pharmaceuticals?
In 2023, Graviti Pharmaceuticals had a promoter holding of 49.00% and a public holding of 51.00%. The company had 3 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Daimen Pharma Private LimitedActive 4 years 1 monthDheeraj Gorukanti and Suguna Raman are mutual person
Yashoda Healthcare Services Private LimitedActive 31 years 4 monthsDheeraj Gorukanti is a mutual person
Fyzks Inspection Systems Private LimitedActive 4 years 1 monthDheeraj Gorukanti and Suguna Raman are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Sep 2023 | ₹118.00 Cr | Open |
Axis Bank Limited Creation Date: 22 Sep 2017 | ₹245.25 Cr | Open |
Axis Bank Limited Creation Date: 31 Mar 2015 | ₹160.00 Cr | Satisfied |
How Many Employees Work at Graviti Pharmaceuticals?
Graviti Pharmaceuticals has a workforce of 605 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Graviti Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Graviti Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
